Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 21, 1999Journal of Medicinal ChemistryOpen Access

Fluorination of 3-(3-(Piperidin-1-yl)propyl)indoles and 3-(3-(Piperazin-1-yl)propyl)indoles Gives Selective Human 5-HT1D Receptor Ligands with Improved Pharmacokinetic Profiles

View Full Paper
Ask AI
Bookmark
Share

Authors

MNMonique B. van NielCharles River Laboratories (United Kingdom)ICIan CollinsInstitute of Cancer ResearchMBMargaret S. BeerMerck & Co., Inc., Rahway, NJ, USA (United States)

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Niel et al. (1999) studied this question.

synapsesocial.com/papers/6a6f2e9035aa2c282ce096c4https://doi.org/10.1021/jm981133m
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Second Generation Antimigraine S-Ht1BID Agonists: Structure Activity Relationship and Preclinical Pharmacological Distinctions1997 · 32 citations
  2. 2Protonated 3-fluoropiperidines: an unusual fluoro directing effect and a test for quantitative theories of solvation1993 · 92 citations
  3. 3Human serotonin 1D receptor is encoded by a subfamily of two distinct genes: 5-HT1D alpha and 5-HT1D beta.1992 · 294 citations
  4. 4Inhibition of the Trigemino-Vascular System with 5-HT 1D Agonist Drugs: Selectively Targeting Additional Sites of Action2008 · 37 citations
  5. 55‐HT1D receptor agonists and human coronary artery reactivity in vitro: crossover comparisons of 5‐HT and sumatriptan with rizatriptan and L‐741,5191996 · 33 citations